ALB
Albemarle Corporation131.07
-1.15-0.87%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q4 '25
Key Stats
Market Cap
15.43BP/E (TTM)
-Basic EPS (TTM)
-1.59Dividend Yield
0.01%Recent Filings
8-K
Director resigns cleanly
8-K
Albemarle sells Ketjen stake
Albemarle agreed to sell a controlling stake in Ketjen's refining catalysts business to KPS affiliates for $800M purchase price, retaining 49% rollover equity, while Ketjen sells its Eurecat JV stake to Axens for €105M (~$125M). Deals unlock ~$660M cash for debt reduction, but trigger $181.5M Q3 goodwill impairment. Closings eyed H1 2026 pending approvals. Regulatory hurdles loom.
8-K
Albemarle appoints new COO
Albemarle announced COO Netha N. Johnson left effective August 10, 2025, amid organizational changes. Mark M. Mummert, 57, succeeds him starting August 11 with $550,000 base salary and $1.4M long-term incentives. Leadership transitions smoothly. Internal promotion leverages his supply chain expertise from Albemarle and prior FMC roles.
10-Q
Q2 FY2025 results
Albemarle posted Q2 revenue of $1.33B, down 7% y/y yet swinging to $197M gross profit from a $11M loss, thanks to lower lithium input costs and 15% volume growth in Energy Storage despite pricing pressure. Operating profit hit $48M from a $493M loss, after lighter $4M restructuring versus $295M last year; diluted EPS loss narrowed to $(0.16) from $(1.96), confirmed against 118M shares with anti-dilution from preferred stock. Cash swelled to $1.81B on $538M YTD operating cash flow, funding $302M capex while free cash flow (derived: $236M YTD) stayed positive; total debt $3.62B includes $445M current. Grace preferred equity redeemed for $288M cash. Lithium pricing weighs on results.
8-K
CEO contract extended to 2027
Albemarle extended CEO J. Kent Masters' employment through March 30, 2027, via amended agreements effective July 30, 2025, citing his leadership for restructuring continuity amid industry volatility. He keeps $1.4M base salary, 150% target bonus. Board locks in expertise. Severance ties to covenants through 2027.
IPO
Website
Employees
Sector
Industry
BCPC
Balchem Corporation
157.10-1.61
CBT
Cabot Corporation
68.00-0.70
CC
Chemours Company (The)
11.69-0.09
CE
Celanese Corporation
40.95-1.54
CHMX
Next-ChemX Corporation
0.01+0.00
CLMT
Calumet, Inc
19.60-0.82
EMN
Eastman Chemical Company
63.65-0.30
ESI
Element Solutions Inc.
25.53-0.53
LYB
LyondellBasell Industries NV
42.98-0.36
SQM
Sociedad Quimica y Minera S.A.
64.17-0.80